CAJ | 학술논문

目的：观察稳心散联合西药治疗气虚血瘀型非 ST段抬高性急性心肌梗死的疗效。方法采用随机、对照方法。将40例气虚血瘀型非 ST段抬高性急性心肌梗死患者,按照随机数字表法分为治疗组和对照组,每组20例。对照组给予阿司匹林、安博维、倍他乐克、立普妥、硝酸甘油和低分子肝素钙等治疗；治疗组在对照组治疗基础上给予稳心散,药用红参、毛冬青根、田七、降香,上药共研为细末,每次6 g,每日3次,温开水冲服。观察两组临床疗效和心脏不良事件。治疗2周后判定疗效。结果治疗组症状总有效率为95%,对照组为75%,治疗组心电图总有效率为90%,对照组为70%,治疗组症状、心电图疗效均优于对照组(P<0.05)；治疗组心脏不良事件率为20%,对照组为50%,治疗组优于对照组(P<0.01)。结论稳心散联合西药治疗气虚血瘀型非ST段抬高性急性心肌梗死疗效满意,对改善心肌梗死症状、心电图缺血性改变和防止心脏不良事件方面疗效显著。
목적：관찰은심산연합서약치료기허혈어형비 ST단태고성급성심기경사적료효。방법채용수궤、대조방법。장40례기허혈어형비 ST단태고성급성심기경사환자,안조수궤수자표법분위치료조화대조조,매조20례。대조조급여아사필림、안박유、배타악극、립보타、초산감유화저분자간소개등치료；치료조재대조조치료기출상급여은심산,약용홍삼、모동청근、전칠、강향,상약공연위세말,매차6 g,매일3차,온개수충복。관찰량조림상료효화심장불량사건。치료2주후판정료효。결과치료조증상총유효솔위95%,대조조위75%,치료조심전도총유효솔위90%,대조조위70%,치료조증상、심전도료효균우우대조조(P<0.05)；치료조심장불량사건솔위20%,대조조위50%,치료조우우대조조(P<0.01)。결론은심산연합서약치료기허혈어형비ST단태고성급성심기경사료효만의,대개선심기경사증상、심전도결혈성개변화방지심장불량사건방면료효현저。
Objective To observe the effect of the Wenxin Powder combined with Western medicine for treatment of non ST segment elevation acute myocardial infarction with qi deficiency and blood stasis syndrome.Methods Forty cases with qi deficiency and blood stasis syndrome and non ST segment elevation acute myocardial infarction were randomly divided into treatment group (n=20)and control group (n= 20).Al patients were given aspirin,An Bowei,Betaloc,Lipitor,nitroglycerin and low molecular weight heparin calcium.Wenxin powder was added to treatment group.Clinical efficacy and adverse cardiac events were observes.Re-sults Total symptoms effective rate was 95% in the treatment group,and that was 75% in the control group.The total effective rate of ECG in the treatment group was 90%,and that was 70% in the control group.The symptoms and ECG curative effect in the treat-ment group was better than the control group (P<0.05).The adverse cardiac event rate in treatment group was 20%,and that was 50% in the control group (P<0.01).Conclusion Wenxin powder and western medicine for treatment of non ST segment elevation acute myocardial infarction with qi deficiency and blood stasis syndrome of is effective,it can improve the symptoms of myocardial in-farction,ischemic electrocardiographic changes,and prevent adverse cardiac events.